CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 359 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02992067
NCT02992067N/ACompleted
CompareCT.gov

CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer

Zhejiang Cancer Hospital·observational·Posted Dec 14, 2016·Updated Oct 4, 2019

In Brief

An observational study for Lymph Node and Breastcancer. Completed, enrolled 359 participants across 1 site.

Detailed Summary

To establish a predicting system on axillary lymph node metastasis based on peripheral blood CK19mRNA and contrast-enhanced ultrasound.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLymph Node, Breastcancer
CountriesChina
CollaboratorsSecond Affiliated Hospital, School of Medicine, Zhejiang University

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 14, 2016
Enrollment StartApr 1, 2015
Primary CompletionApr 1, 2017
Study CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 9.5 years ago